Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Task Force Advocates Making Registries Better Than Sum Of Their Parts

This article was originally published in The Gray Sheet

Executive Summary

The FDA-endorsed Medical Device Registry Task Force maps out a path toward "coordinated registry networks," starting with pilot projects and 11 prioritized device categories.


Related Content

CDRH Prioritizes Leveraging Real-World And Patient-Preference Data, Enhancing Quality
Postmarket Surveillance Reform Board Gets Injection Of Device Industry Experience
Device Surveillance Reform Board Looks To Add Small-Firm Experience
Planning Board Proposes Postmarket Device Surveillance Timeline
CDRH Details Path Forward For National Post-Market Surveillance System





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts